STRO
Companies
NASDAQ
Sutro Biopharma Inc.
Health Care
$0.79
-$1.05 (-57.07%)
Price Chart
Overview
About STRO
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Market Cap
$303.5M
Volume
1.2M
Avg. Volume
1.7M
P/E Ratio
-0.30488294
Dividend Yield
0.00%
Employees
292.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.78
High Correlation
Volatility
High (0.81)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, STRO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$303.5M
Volume1.2M
P/E Ratio-0.30
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025